Grants and Contributions

The specific objectives of this funding opportunity are:

• Catalyze community-led research planning and development activities in Canada that ensure the inclusion and meaningful representation of people experiencing climate change-related health impacts;
• Foster meaningful and equitable partnerships between communities in Canada impacted by climate change and researchers to advance research focused on community-driven priorities;
• Engage impacted communities to strengthen capacity for knowledge mobilization; and/or,
• Better position teams of researchers and community partners to develop applications for future funding in support of co-developed CBR climate change research and knowledge mobilization projects/programs.

The specific objectives of this funding opportunity are:

• Catalyze community-led research planning and development activities in Canada that ensure the inclusion and meaningful representation of people experiencing climate change-related health impacts;
• Foster meaningful and equitable partnerships between communities in Canada impacted by climate change and researchers to advance research focused on community-driven priorities;
• Engage impacted communities to strengthen capacity for knowledge mobilization; and/or,
• Better position teams of researchers and community partners to develop applications for future funding in support of co-developed CBR climate change research and knowledge mobilization projects/programs.

The specific objective of this funding opportunity is to:

• Catalyze and support research efforts of Canadian researchers to use the available CLSA data in order to better understand how biological, medical, psychological, social, lifestyle and/or economic aspects of people’s lives have an impact on both maintaining health and the development of disease and disability as people age.

The specific objective of this funding opportunity is to:

• Catalyze and support research efforts of Canadian researchers to use the available CLSA data in order to better understand how biological, medical, psychological, social, lifestyle and/or economic aspects of people’s lives have an impact on both maintaining health and the development of disease and disability as people age.

This award was established to recognize the excellence of cancer research being conducted in Canada. This award will be given annually to the highest-ranking Early Career Researchers in the Project Grant competition that fall within the CIHR Institute of Cancer Research (CIHR-ICR) mandate:

• ICR has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

This Priority Announcement (PA) is led by Canada’s Strategy for Patient-Oriented Research in partnership with CIHR’s Knowledge Mobilization Strategies team and aims to support Patient-Oriented Research (POR) with a focus on mobilizing knowledge for research impacts.

Patient-Oriented Research, which is foundational to evidence-informed health care, refers to a continuum of research that engages patients and communities, including People with Lived and Living Experience (PWLLE), as partners throughout the research process, focusses on patient-identified priorities, and improves patient outcomes. This research, conducted by multidisciplinary teams in collaboration with relevant partners, aims to apply the knowledge generated to improve health outcomes for Canadians.

Canada’s¿Strategy for Patient-Oriented Research (SPOR)¿is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, community members, health authorities, academic health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of patient-oriented research into care. The vision for SPOR is that Canada will demonstrably improve health outcomes and enhance the health care experience for patients through the integration of evidence at all levels of the health care system.

The CIHR HIV/AIDS and Sexually Transmitted and Blood-Borne Infections (STBBI) Research Initiative, under the leadership of the CIHR Institute of Infection and Immunity (CIHR-III), defines STBBI as infections that are transmitted primarily through exchange of body fluids during sexual contact and/or through blood, and supports projects with a primary focus on STBBI of public health relevance, including but not limited to HIV/AIDS, chlamydia, gonorrhea, syphilis, hepatitis B, hepatitis C and human papillomavirus. This funding is provided across all CIHR research themes: biomedical research, clinical research, health services research and social, cultural, environmental and population health research.
Research that focuses on key populations disproportionately affected by HIV/AIDS and STBBI is highly encouraged.
In alignment with CIHR's commitment to equity, diversity and inclusion (EDI) in the research system, the Research Initiative champions EDI as a means to support excellence in research, training and knowledge mobilization. Therefore, we encourage people from diverse backgrounds, including groups underrepresented in science such as women and racial and ethnic minorities, to apply.
This Priority Announcement will prioritize funding for research on HIV/AIDS and/or STBBI aligned with the CIHR HIV/AIDS Research Initiative: Strategic Plan (2022-2027) in the following research areas:
• Improving health equity by advancing research to understand and address determinants of health, new models of care, or sexual and reproductive health for people living with or at risk of HIV/AIDS and STBBI; or
• Accelerating discovery and innovation by advancing research on innovative technologies for testing and surveillance, interactions among infections and co-morbidities, or design and development of next-generation interventions.

CIHR is committed to leverage the power of research to accelerate global health equity for all. The CIHR Framework for Action on Global Health Research 2021-2026 recognizes that CIHR must work globally because today’s most pressing health problems, and many of the most effective strategies to prevent, contain, and address them, are global. In alignment with this Framework, this priority announcement aims to grow global health research capacity and excellence.
Funding will be provided for applications that have a primary focus on global health research (as per CIHR’s definition) and that are relevant to one of the mandates below:
• Centre for Research on Pandemic Preparedness and Health Emergencies (CRPPHE)
• Institute of Population and Public Health (IPPH)

CIHR is committed to leverage the power of research to accelerate global health equity for all. The CIHR Framework for Action on Global Health Research 2021-2026 recognizes that CIHR must work globally because today’s most pressing health problems, and many of the most effective strategies to prevent, contain, and address them, are global. In alignment with this Framework, this priority announcement aims to grow global health research capacity and excellence.
Funding will be provided for applications that have a primary focus on global health research (as per CIHR’s definition) and that are relevant to one of the mandates below:
• Centre for Research on Pandemic Preparedness and Health Emergencies (CRPPHE)
• Institute of Population and Public Health (IPPH)

The CIHR Institute of Infection and Immunity (CIHR-III) will fund applications that are determined to be specifically relevant to its mandate and its 2021-2026 Strategic Plan, with a primary focus on biomedical research in which the objective and aims are directed towards building foundational knowledge in immunology and/or infectious diseases.

This Priority Announcement will prioritize funding for research in the following research areas:

• Infection:
o Zoonotic or vector-borne transmission of pathogens in the context of Global Climate Change;
o Understanding functional genomics and/or molecular epidemiology of emerging/re-emerging pathogens;
o Resistance to fungal infections and/or the role of bacteriophages in combatting antimicrobial resistance (AMR).
• Immunity:
o Immune mechanisms involved in the development of trained innate immunity;
o Immune mechanisms involved in the development and maintenance of tissue-specific immunity;
o Metabolic regulation of immune cells and processes (immunometabolism).

Should there be no eligible applications relevant to the research areas identified above, III will fund applications that are relevant to its mandate and its 2021-2026 Strategic Plan, with a primary focus on biomedical research in which the objective and aims are directed towards building foundational knowledge in immunology and/or infectious diseases.